Tenax Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TENX) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M Cash from investing activities 00000 0 Cash from financing activities 92.01 M67 K23.56 M278 K3.06 M 26.97 M Free cash flow -3.09 M-3.53 M-6.97 M-6.26 M-9.15 M -25.91 M

ニュース

Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)

Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)

Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing

Tesla, Goldman Sachs among market cap stock movers on Monday

Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target

Obiettivo di prezzo di Tenax Therapeutics alzato a $25 da $14 da Guggenheim

Tenax Therapeutics stock price target raised to $25 from $14 at Guggenheim

Il direttore di Tenax Therapeutics Rich Stuart acquista azioni per $50.792

Tenax Therapeutics director Rich Stuart buys $50,792 in stock

Giordano buys Tenax Therapeutics (TENX) shares worth $19,999

Il CFO ad interim di Tenax Therapeutics McGauley acquista azioni per $58.164

Tenax Therapeutics interim CFO McGauley buys shares worth $58,164